BioAffinity Technologies Revenue and Competitors
Estimated Revenue & Valuation
- BioAffinity Technologies's estimated annual revenue is currently $4.5M per year.
- BioAffinity Technologies's estimated revenue per employee is $155,000
Employee Data
- BioAffinity Technologies has 29 Employees.
- BioAffinity Technologies grew their employee count by 0% last year.
BioAffinity Technologies's People
Name | Title | Email/Phone |
---|---|---|
1 | VP Diagnostics | Reveal Email/Phone |
BioAffinity Technologies Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $99.4M | 458 | 40% | N/A | N/A |
#2 | $20.6M | 133 | 22% | N/A | N/A |
#3 | $156.1M | 146 | -70% | $145M | N/A |
#4 | $3.5M | 45 | -25% | $150M | N/A |
#5 | $1.6M | 21 | 0% | $459.5M | N/A |
#6 | $67.3M | 310 | 16% | $180.7M | N/A |
#7 | $8.5M | 55 | -2% | N/A | N/A |
#8 | $256.3M | 1025 | 9% | $168.5M | N/A |
#9 | $2.8M | 18 | -33% | N/A | N/A |
#10 | $9.1M | 59 | -9% | N/A | N/A |
What Is BioAffinity Technologies?
N/A
Total Funding
29
Number of Employees
$4.5M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
BioAffinity Technologies News
2022-04-20 - bioAffinity Technologies Files For U.S. IPO
bioAffinity Technologies has filed to raise capital via a U.S. IPO. The firm is developing a lung cancer detection test for use in the U.S....
2022-04-17 - Lung cancer diagnostics developer bioAffinity Technologies ...
bioAffinity Technologies, which has developed a noninvasive test for early detection of lung cancer, filed on Monday with the SEC to raise...
2022-04-17 - Lung cancer test developer BioAffinity files for $19M IPO
BioAffinity Technologies (BIAF), which is developing a test to better detect lung cancer in its earliest stages, has filed for a $19M...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $2M | 29 | 32% | $7M |
#2 | $7.5M | 29 | 0% | N/A |
#3 | $5M | 29 | 7% | N/A |
#4 | $2.9M | 29 | N/A | N/A |
#5 | $1.7M | 29 | N/A | N/A |